Lion Biotechnologies, Inc.
Lion Biotechnologies, Inc. (LBIO) is a publicly traded company in the Unknown sector. Across all available filings, 10 corporate insiders have executed 28 transactions totaling $29.9M, demonstrating a bearish sentiment with -$29.2M in net insider flow. The most recent transaction on Aug 25, 2016 involved a sale of 20,500 shares valued at $178.6K.
LBIO Insider Activity Summary
Who Is Buying LBIO Stock?
No significant insider buying has been recorded for LBIO in the recent period.
Who Is Selling LBIO Stock?
No significant insider selling has been recorded for LBIO in the recent period.
Is Lion Biotechnologies, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for LBIO is bearish with an Insider Alignment Score of 1/100 and a net flow of -$29.2M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
LBIO Frequently Asked Questions
Understanding LBIO Insider Activity
Insider trading at Lion Biotechnologies, Inc. (LBIO) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 10 insiders are actively trading LBIO stock, having executed 28 transactions in the past 90 days. The most active insider is Capital Partners, Llc Acm (Executive), who has made 1 transactions totaling $26.8M.
Related Tools
Track Lion Biotechnologies, Inc. Insider Activity
Get notified when executives and directors at LBIO file new Form 4 transactions